Evidence map›Paper›PMID 28265882›Full record

ReviewJournal of cardiovascular translational research2017

Cardiovascular Bio-Engineering: Current State of the Art.

Teresa Simon-Yarza, Isabelle Bataille, Didier Letourneur

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of cardiovascular translational research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Latest Advances in 3D Bioprinting of Cardiac Tissues.Advanced materials technologies · 2022
    Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Tissue Engineering-Bridging the Gap.Journal of cardiovascular translational research · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Teresa Simon-YarzaInserm U1148, LVTS, X. Bichat Hospital, University Paris Diderot, 46 rue H Huchard, 75018, Paris, France.
Isabelle BatailleInserm U1148, LVTS, X. Bichat Hospital, University Paris Diderot, 46 rue H Huchard, 75018, Paris, France.
Didier LetourneurInserm U1148, LVTS, X. Bichat Hospital, University Paris Diderot, 46 rue H Huchard, 75018, Paris, France. didier.letourneur@inserm.fr.ORCID http://orcid.org/0000-0003-2197-9468

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the introduction of new drugs and innovative devices contributing in the last years to improve patients' quality of life, morbidity and mortality from cardiovascular diseases remain high. There is an urgent need for addressing the underlying problem of the loss of cardiac or vascular tissues and therefore developing new therapies. Autologous vascular transplants are often limited by poor quality of donor sites and heart organ transplantation by donor shortage. Vascular and cardiac tissue engineering, whose aim is to repair or replace cardiovascular tissues by the use of cells, engineering and materials, as well as biochemical and physicochemical factors, appears in this scenario as a promising tool to repair the damaged hearts and vessels. We will present a general overview on the fundamentals in the area of cardiac and vascular tissue engineering as well as on the latest progresses and challenges.

Indexed as

BioprosthesisRegenerative MedicineTissue EngineeringTissue ScaffoldsAnimalsCardiac Surgical ProceduresCardiovascular DiseasesHumansMyocardiumMyocytes, CardiacProsthesis DesignRecovery of FunctionRegenerationStem Cell TransplantationCardiac repairTissue engineeringVascular prostheses

Identifiers

PMID28265882

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.